1. Home
  2. FEMY vs DTST Comparison

FEMY vs DTST Comparison

Compare FEMY & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • DTST
  • Stock Information
  • Founded
  • FEMY 2004
  • DTST 2001
  • Country
  • FEMY United States
  • DTST United States
  • Employees
  • FEMY N/A
  • DTST N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • DTST EDP Services
  • Sector
  • FEMY Health Care
  • DTST Technology
  • Exchange
  • FEMY Nasdaq
  • DTST Nasdaq
  • Market Cap
  • FEMY 31.9M
  • DTST 28.2M
  • IPO Year
  • FEMY 2021
  • DTST N/A
  • Fundamental
  • Price
  • FEMY $0.91
  • DTST $3.53
  • Analyst Decision
  • FEMY Strong Buy
  • DTST
  • Analyst Count
  • FEMY 3
  • DTST 0
  • Target Price
  • FEMY $8.67
  • DTST N/A
  • AVG Volume (30 Days)
  • FEMY 280.4K
  • DTST 29.6K
  • Earning Date
  • FEMY 08-07-2025
  • DTST 08-13-2025
  • Dividend Yield
  • FEMY N/A
  • DTST N/A
  • EPS Growth
  • FEMY N/A
  • DTST N/A
  • EPS
  • FEMY N/A
  • DTST 0.02
  • Revenue
  • FEMY $1,699,232.00
  • DTST $25,219,312.00
  • Revenue This Year
  • FEMY $231.84
  • DTST $12.57
  • Revenue Next Year
  • FEMY $245.28
  • DTST $9.29
  • P/E Ratio
  • FEMY N/A
  • DTST $149.84
  • Revenue Growth
  • FEMY 61.97
  • DTST N/A
  • 52 Week Low
  • FEMY $0.69
  • DTST $2.93
  • 52 Week High
  • FEMY $1.80
  • DTST $6.53
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 50.88
  • DTST 49.28
  • Support Level
  • FEMY $0.90
  • DTST $3.33
  • Resistance Level
  • FEMY $0.99
  • DTST $3.56
  • Average True Range (ATR)
  • FEMY 0.07
  • DTST 0.13
  • MACD
  • FEMY 0.01
  • DTST 0.02
  • Stochastic Oscillator
  • FEMY 39.48
  • DTST 70.00

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About DTST Data Storage Corporation

Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.

Share on Social Networks: